Maya Patel

ConvaTec wins FDA approval for Parkinson's treatment infusion tech

ConvaTec Group Plc began 2025 with strong momentum, continuing its trajectory of growth driven by product portfolio expansion and regulatory approvals. The company remains committed to innovation and operational excellence, enhancing its chronic care solutions to improve patient outcomes. Analysts maintain a favorable outlook, highlighting ConvaTec's strategic focus and potential for significant future growth.

July 18, 2025 at 04:30 pm IST

Halozyme Therapeutics' strategic adoption

Halozyme Therapeutics demonstrated a robust Q1 25, showcasing substantial net income growth. The latest financial results highlight strong fundamentals, driven by the accelerating adoption of its proprietary ENHANZE technology and innovative product offerings. These advancements are expected to be value-accretive and bolster the company's revenue growth. Overall, analysts have positive views on Halozyme Therapeutics, reflecting confidence in its future prospects.

July 16, 2025 at 03:09 pm IST

Intuit Inc. launches virtual team of AI agents to fuel growth

Intuit Inc. has delivered strong Q3 25 results, driven by AI innovations and product expansion. It posted significant revenue growth, with EBIT and net profit also increasing substantially. The stock has shown impressive gains over the past year; BMO Capital and Deutsche Bank have also increased their target prices for the share, reflecting both positive analyst sentiment and the company's robust performance.

July 14, 2025 at 02:21 pm IST

Indian Hotels target tourism boom with boutique acquisitions

At the AGM on July 7, 2025, N Chandrasekaran, Indian Hotels Company Limited's chairman, announced plans to acquire boutique hotels to meet growing tourism demand. He emphasized the need for clean, quality hotels across India and highlighted IHCL's strategy to build hotels at various price points for different customer segments. The company aims for a 50:50 share of owned and managed properties and plans selective overseas expansion in cities with promising opportunities.

July 10, 2025 at 01:23 pm IST

Tecnoglass' strong Q1 performance driven by expansion in market share

Tecnoglass Inc. has posted robust Q1 2025 numbers, achieving record net sales and operating income. The impressive results have been driven by market share gains in single-family and multi-family/commercial sectors, alongside strong execution on high-profile projects. In addition, the company has bolstered growth through strategic acquisitions, which continue to be a key component of its expansion strategy.

July 09, 2025 at 02:52 pm IST

Sprouts Farmers Market's growth through expansion

Sprouts Farmers Market, Inc. has started 2025 on a strong note, with Q1 performance exceeding guidance, driven by expansion and performance of new stores. The company continues to focus on enhancing its value proposition through strategic growth initiatives, including the opening of new stores to improve access to fresh, natural, and organic food options. In paricular, Sprouts has surpassed analyst revenue expectations for the seventh consecutive quarter.

July 07, 2025 at 02:30 pm IST

Palantir Technologies: Continued traction in the US commercial business

Palantir Technologies has reported a positive start to the year, with rapid traction in the US business. US commercial continues to drive revenue, with an impressive rise in clients, amidst increased software applications in commercial enterprises. As a result, in its latest quarterly period, the group reported the highest US commercial TCV.

July 03, 2025 at 04:10 pm IST

Market rally and IPO boom in key markets fueling Futu Holdings’ growth

Futu Holdings has started 2025 on a strong footing, posting a robust rise in key metrics performance. In its latest quarterly results, the company reported an impressive increase in the number of funded accounts, users and client assets, highlighting the strong brand equity it enjoys in its operating markets.

July 02, 2025 at 04:21 pm IST

Stride rides on higher enrollment

Stride has demonstrated remarkable performance so far this year, with Q3 25 results reflecting substantial growth. The company's latest earnings report reveals significant growth in both revenue and profit, fueled by higher enrollment and expanded curriculum offerings. In particular, Stride has exceeded analysts' revenue expectations for the seventh consecutive quarter, underscoring its robust financial health and strategic progress.

June 30, 2025 at 04:50 pm IST

Cloud first strategy driving results for Tyler Technologies

Tyler Technologies started 2025 on a positive note, with a continued rise in SaaS revenues for the 17th consecutive quarter. This trend reflects the group’s cloud-first strategy, along with focus on expanding the TAM to leverage on growing opportunities in the public sector software market. The company stands to gain on its 6% market share of the fragmented $21bn market.

June 27, 2025 at 04:51 pm IST

Exelixis Q1 25 results boost stock and target price

Exelixis has started the financial year with robust performance, driven by impressive Q1 25 results and positive clinical trial outcomes. The company's latest financials highlight strong demand for CABOMETYX and significant growth in revenue, operating income and net profit. These positive trial results further strengthen Exelixis's market position. As a result of these accomplishments, Stephens has raised its target price for the share, leading to a significant rise of over 20% in the company's stock the day after the announcement.

June 25, 2025 at 05:41 pm IST

Grand Canyon Education paints an optimistic outlook

Grand Canyon Education has started the year on a positive note with a rise in service revenue from increased partner enrollments. The company’s optimistic guidance levels and encouraging performance have pushed the stock higher over the past year. However, competition from other emerging companies in this space may need to be watched out in the future.

June 24, 2025 at 05:23 pm IST

Fastenal’s fasteners recover in Q1 25 after prolonged slump

In Q1 25, the fasteners segment finally posted growth, after seven consecutive quarters of stagnation or declines. This improvement was attributed to easier y/y comparisons and big customer signings. Safety supplies continued their steady rise, while other product lines maintained their growth, primarily driven by MRO-oriented products. Consequently, overall revenue increased.

June 23, 2025 at 05:47 pm IST

CSW Industrials reports robust FY 25 results

CSW Industrials witnessed a solid yearly performance, demonstrating significant net income growth for FY 25. The company's latest financial results reveal strong fundamentals, supported by strategic acquisitions and advanced product offerings. The acquisitions provide an opportunity to be value-accretive and support the revenue expansion of the group. Overall, analysts have favorable opinions about the company.

June 20, 2025 at 05:53 pm IST

Amphenol's Q1 25 results boost share price and analyst’s targets

Amphenol Corporation released its Q1 25 results on April 23, 2025, including a remarkable 47.7% y/y increase in revenue to $4,811m. Operating income surged 49.7% y/y to $1,024.8m, with margins expanding by 27bp to 21.3%. Net profit rose 34% y/y to $737.8m. Following these strong results, Fox Advisors and Goldman Sachs updated their target prices for Amphenol to $110 and $102, respectively. The announcement led to an 8.2% rise in the share's price on the results day, with the stock increasing 21.7% since then.

June 17, 2025 at 03:38 pm IST

Universal Health posts decent top-line performance in Q1 25

Universal Health released its Q1 25 results on April 28, 2025, reporting a decent rise of 6.7% y/y in net revenues to US$4.1bn. Adjusted net attributable profit increased to US$319.5m or US$4.8 per diluted share, compared to US$253.1m or US$3.7 per diluted share in Q1 24. The stock price was volatile on the result day but gradually recovered in the following days to reach around US$199 levels on May 16, 2025. However, since then, the stock is facing selling pressure on account of recent Medicaid bill pushed by Republicans for proposed cuts to the health insurance program.

June 13, 2025 at 04:21 pm IST

National Bank of Canada’s shares surge after strong Q2 25 NII

National Bank of Canada reported encouraging Q2 25 results, NII rose 90% y/y to CAD1.2bn, driven by strong organic growth across all business segments. Total deposits surged by 23% to CAD294bn, while total loans grew by 22% to CAD286bn. The bank has consistently exceeded analyst revenue estimates for the past seven quarters, surpassing expectations by 10.1% in Q2 25. Following the announcement, shares rose by 3.8%.

June 12, 2025 at 04:47 pm IST

Mebuki Financial Group: update on acquisition of own shares

Mebuki Financial Group provided an update on the acquisition of its own shares on June 2, 2025, reporting acquisition of 6,161,200 shares of common stock from May 1, 2025, to May 31, 2025, with a total acquisition cost of JPY4.3bn. This acquisition is part of a resolution dated April 7, 2025, which allows for the acquisition of up to 45,000,000 shares at a cost of up to JPY23bn from April 8, 2025, to June 20, 2025. As of May 31, 2025, the cumulative total of shares acquired is 34,734,000 shares at a cost of JPY19.9bn.

June 10, 2025 at 06:15 pm IST

AREIT, Inc. stellar results, fueled by property expansion

AREIT, Inc. released its Q1 25 results on May 13, 2025, posting impressive growth in both revenue and profits, driven by contributions from newly acquired properties in July 2024. Revenue surged by 38% y/y to PHP2.9bn. Operating income rose 42%, reaching PHP2.1bn, with margins improving by 136bp to 73.3%. Consequently, net profit grew by 43% y/y to PHP2.1bn.

June 09, 2025 at 05:16 pm IST

Arab National Bank: Stable risk metrics owing to quality assets

Arab National Bank reported encouraging Q1 25 results, supported by an expanding non-oil Saudi economy. Loans and advances rose 13.4% y/y to SAR179.1bn, driven by strong growth in the corporate lending segment. Customers’ deposits grew in sync at 12.1% to SAR195.6bn. Cost of risk remained steady with only 2bp increase to 40bp, underpinning stable quality of loan book.

June 05, 2025 at 04:37 pm IST

Ain Holdings expands network with acquisition of Sakura pharmacy

Ain Holdings will acquire NSSK-WW and NSSK-W, the holding companies of Sakura Pharmacy Group, for approximately JPY59.1bn, according to a Tokyo bourse filing on May 29, 2025. This acquisition will make Sakura Pharmacy Group, with 800 pharmacies, a subsidiary of Ain Holdings, expanding Ain's network to over 2,000 stores and strengthening its position in Japan's healthcare sector.

June 04, 2025 at 03:23 pm IST